Bohyun Byun

Title: Bohyun Byun: Innovator in Cancer Detection Technology

Introduction

Bohyun Byun is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer diagnostics through his innovative research and development efforts. His work focuses on the detection of genetic mutations that can influence cancer treatment outcomes.

Latest Patents

Bohyun Byun holds a patent for a composition designed for detecting epidermal cell growth factor receptor (EGFR) gene mutations. The patent, titled "Composition for detecting epidermal cell growth factor receptor gene mutation, and kit comprising same," outlines a primer and probe set composition that facilitates the detection of EGFR gene mutations. This invention is crucial for predicting and diagnosing a patient's responsiveness to therapeutic agents, as well as for monitoring potential cancer metastasis or relapse. The method developed can guide treatment decisions and improve patient outcomes.

Career Highlights

Bohyun Byun is currently associated with Gencurix Inc., a company dedicated to advancing cancer diagnostics. His role at Gencurix allows him to apply his expertise in molecular biology and genetics to develop innovative solutions for cancer detection and treatment.

Collaborations

Bohyun Byun has collaborated with esteemed colleagues such as Young Kee Shin and Hyunjeung Choi. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of cancer diagnostics.

Conclusion

Bohyun Byun's contributions to cancer detection technology exemplify the impact of innovative research on healthcare. His patent for detecting EGFR gene mutations represents a significant advancement in the field, with the potential to improve cancer treatment strategies.